P2RY12 and chronic kidney disease: Similarly, Angiolillo et al. observed that diabetic patients with CKD had markedly elevated platelet reactivity with a reduced response to the active metabolite of clopidogrel, suggesting altered P2Y12-mediated signaling [127].